Advertisement
MED vs NCLH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MED is a StrongBuy and NCLH is a StrongBuy.
MED's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for MED turned positive on October 14, 2026. Looking at past instances where MED's MACD turned positive, the stock continued to rise in 37 of 58 cases over the following month. The odds of a continued upward trend are 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on MED as a result. In 58 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
MED moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MED crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in 150 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
MED broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MED entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.689) is normal, around the industry mean (7.621). MED has a moderately low P/E Ratio (-5.193) as compared to the industry average of (10.681). Projected Growth (PEG Ratio) (0.230) is also within normal values, averaging (4.440). MED's Dividend Yield (0.545) is considerably higher than the industry average of (0.080). P/S Ratio (0.416) is also within normal values, averaging (1.645).
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. MED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
NCLH's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for NCLH turned positive on September 22, 2026. Looking at past instances where NCLH's MACD turned positive, the stock continued to rise in 32 of 41 cases over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NCLH's RSI Oscillator exited the oversold zone, 22 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on NCLH as a result. In 60 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
Following a +3.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where NCLH advanced for three days, in 219 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 186 of 247 cases where NCLH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 60 cases where NCLH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCLH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
NCLH broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.782) is normal, around the industry mean (0.391). P/E Ratio (9.335) is within average values for comparable stocks, (25.274). Projected Growth (PEG Ratio) (1.195) is also within normal values, averaging (1.617). Dividend Yield (0.000) settles around the average of (0.185) among similar stocks. P/S Ratio (0.699) is also within normal values, averaging (2.686).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. NCLH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCLH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
MED | NCLH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 28 | |
PRICE GROWTH RATING 1..100 | 44 | 60 | |
P/E GROWTH RATING 1..100 | 97 | 84 | |
SEASONALITY SCORE 1..100 | 39 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MED's Valuation (3) in the Specialty Stores industry is somewhat better than the same rating for NCLH (60) in the Hotels Or Resorts Or Cruiselines industry. This means that MED’s stock grew somewhat faster than NCLH’s over the last 12 months.
MED's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as NCLH (100) in the Hotels Or Resorts Or Cruiselines industry. This means that MED’s stock grew similarly to NCLH’s over the last 12 months.
NCLH's SMR Rating (28) in the Hotels Or Resorts Or Cruiselines industry is significantly better than the same rating for MED (94) in the Specialty Stores industry. This means that NCLH’s stock grew significantly faster than MED’s over the last 12 months.
MED's Price Growth Rating (44) in the Specialty Stores industry is in the same range as NCLH (60) in the Hotels Or Resorts Or Cruiselines industry. This means that MED’s stock grew similarly to NCLH’s over the last 12 months.
NCLH's P/E Growth Rating (84) in the Hotels Or Resorts Or Cruiselines industry is in the same range as MED (97) in the Specialty Stores industry. This means that NCLH’s stock grew similarly to MED’s over the last 12 months.
| MED | NCLH | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 76% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 61% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 64% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 66% | 1 day ago 80% |
| Advances ODDS (%) | 1 day ago 62% | 3 days ago 77% |
| Declines ODDS (%) | 15 days ago 83% | 1 day ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MED’s FA Score shows that 1 FA rating(s) are green while NCLH’s FA Score has 1 green FA rating(s).
- MED’s FA Score: 1 green, 4 red.
- NCLH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MED’s TA Score shows that 4 TA indicator(s) are bullish while NCLH’s TA Score has 5 bullish TA indicator(s).
- MED’s TA Score: 4 bullish, 5 bearish.
- NCLH’s TA Score: 5 bullish, 3 bearish.
Price Growth
MED (@Personnel Services) experienced а +2.11% price change this week, while NCLH (@Consumer Sundries) price change was +0.97% for the same time period.
The average weekly price growth across all stocks in the @Personnel Services industry was +2.92%. For the same industry, the average monthly price growth was +2.23%, and the average quarterly price growth was -7.09%.
The average weekly price growth across all stocks in the @Consumer Sundries industry was -1.53%. For the same industry, the average monthly price growth was +3.29%, and the average quarterly price growth was +5.81%.
Reported Earning Dates
MED is expected to report earnings on Oct 26, 2026.
NCLH is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Personnel Services (+2.92% weekly)Personnel Services comprise companies that provide staffing and human resources management solutions for businesses. Each company might be involved in one or more types of recruitment or employee solutions such as permanent or temporary staffing, career consulting, outsourcing, administrative services and many more. Some personnel services companies cater to large businesses, while some specialize in providing services to small/medium-sized organizations. These specialized services potentially expedite the process of getting the ‘right’ candidates and/or training them to meet the requirements of a business process. Some of the companies also cover other critical areas like internal auditing for a company. Robert Half International Inc., ManpowerGroup Inc. and Insperity, Inc. are examples of companies in the personnel services industry.
@Consumer Sundries (-1.53% weekly)Consumer sundries companies make products that usually do not have another classification, such as lawn and garden products, pest-control products, pet food and pet products like leashes, collars, and harnesses. Central Garden & Pet Company and Dogness (International) Corporation are examples of companies operating in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TUA | 19.60 | 0.32 | +1.66% |
| Simplify Short Term Treasury Futures Strategy ETF (TUA) | |||
| PFO | 8.48 | -0.01 | -0.12% |
| Flaherty & Crumrine Preferred and Income Opportunity Fund | |||
| NVIR | 39.63 | -0.18 | -0.45% |
| Horizon Kinetics Energy and Remediation ETF (NVIR) | |||
| ISMF | 28.54 | -0.24 | -0.83% |
| iShares Managed Futures Active ETF (ISMF) | |||
| CGIE | 36.13 | -0.39 | -1.07% |
| Capital Group International Equity ETF (CGIE) | |||